UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gray matter atrophy in multiple sclerosis: A longitudinal study

Annals of neurology, 2008-09, Vol.64 (3), p.255-265

2008

Volltextzugriff (PDF)

Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study

Lancet neurology, 2018-10, Vol.17 (10), p.870-884

2018

Volltextzugriff (PDF)

Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study

Neurology, 2014-07, Vol.83 (1), p.78-86

2014

Volltextzugriff (PDF)

Reliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinic

JAMA neurology, 2013-03, Vol.70 (3), p.338

2013

Volltextzugriff (PDF)

Imaging correlates of axonal swelling in chronic multiple sclerosis brains

Annals of neurology, 2007-09, Vol.62 (3), p.219-228

2007

Volltextzugriff (PDF)

Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosis

PloS one, 2011, Vol.6 (5), p.e19262

2011

Volltextzugriff (PDF)

Measuring treatment response to advance precision medicine for multiple sclerosis

Annals of clinical and translational neurology, 2021-11, Vol.8 (11), p.2166-2173

2021

Volltextzugriff (PDF)

Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability

Annals of clinical and translational neurology, 2021-05, Vol.8 (5), p.1096-1109

2021

Volltextzugriff (PDF)

Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data

Neurology, 2019-11, Vol.93 (21), p.e1921

2019

Volltextzugriff (PDF)

Validation of a Self-Report Comorbidity Questionnaire for Multiple Sclerosis

Neuroepidemiology, 2010-08, Vol.35 (2), p.83-90

2010

Volltextzugriff (PDF)

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS

Journal of the neurological sciences, 2009-07, Vol.282 (1), p.106-111

2009

Volltextzugriff (PDF)

Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis

Neurology, 2024-05, Vol.102 (9), p.e209357

2024

Volltextzugriff (PDF)

The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosis

JAMA neurology, 2014-11, Vol.71 (11), p.1386

2014

Volltextzugriff (PDF)

Multiple Sclerosis Performance Test: Technical Development and Usability

Advances in therapy, 2019-07, Vol.36 (7), p.1741-1755

2019

Volltextzugriff (PDF)

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

Journal of neurology, 2009-03, Vol.256 (3), p.405-415

2009

Volltextzugriff (PDF)

Early tolerability and safety of fingolimod in clinical practice

Journal of the neurological sciences, 2012-12, Vol.323 (1), p.167-172

2012

Volltextzugriff (PDF)

Experience with fingolimod in clinical practice

International journal of neuroscience, 2015-09, Vol.125 (9), p.678-685

2015

Volltextzugriff (PDF)

Factors associated with clinically significant increased walking time in multiple sclerosis: Results of a survival analysis of short-term follow-up data from a clinical database

Multiple sclerosis, 2015-04, Vol.21 (4), p.457-465

2015

Volltextzugriff (PDF)

Web-based self-management for patients with multiple sclerosis: a practical, randomized trial

Telemedicine journal and e-health, 2011-01, Vol.17 (1), p.5-13

2011

Volltextzugriff (PDF)

Primary progressive multiple sclerosis as a phenotype of a PLP1 gene mutation

Annals of neurology, 2005-09, Vol.58 (3), p.470-473

2005

Volltextzugriff (PDF)

Sex differences in cytokine responses to myelin peptides in multiple sclerosis

Journal of neuroimmunology, 2002-09, Vol.130 (1), p.211-223

2002

Volltextzugriff (PDF)

Quantification of Self-Recognition in Multiple Sclerosis by Single-Cell Analysis of Cytokine Production

The Journal of immunology (1950), 2000-08, Vol.165 (3), p.1641-1651

2000

Volltextzugriff (PDF)

Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis

Multiple sclerosis, 2005-08, Vol.11 (4), p.409-419

2005

Volltextzugriff (PDF)

Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications

Multiple sclerosis, 2005-04, Vol.11 (2), p.140-145

2005

Volltextzugriff (PDF)

Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression

Journal of neuroimmunology, 2003-08, Vol.141 (1), p.132-140

2003

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

Humans
(56)
Female
(54)
Science & Technology
(54)
Life Sciences & Biomedicine
(53)
Male
(53)
Adult
(51)
Neurosciences & Neurology
(42)
Clinical Neurology
(37)
Biological And Medical Sciences
(28)
Medical Sciences
(27)
Multiple Sclerosis
(26)
Neurology
(25)
Neurosciences
(25)
Aged
(15)
Magnetic Resonance Imaging
(14)
Disability Evaluation
(13)
Multiple Sclerosis - Pathology
(13)
Brain - Pathology
(12)
Multiple Sclerosis - Physiopathology
(12)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gray matter atrophy in multiple sclerosis: A longitudinal study

Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study

Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study

Reliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinic

Imaging correlates of axonal swelling in chronic multiple sclerosis brains

Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosis

Measuring treatment response to advance precision medicine for multiple sclerosis

Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability

Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data

Validation of a Self-Report Comorbidity Questionnaire for Multiple Sclerosis

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS

Temporal Relationship Between Serum Neurofilament Light Chain and Radiologic Disease Activity in Patients With Multiple Sclerosis

The clinical meaning of walking speed as measured by the timed 25-foot walk in patients with multiple sclerosis

Multiple Sclerosis Performance Test: Technical Development and Usability

The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

Early tolerability and safety of fingolimod in clinical practice

Experience with fingolimod in clinical practice

Factors associated with clinically significant increased walking time in multiple sclerosis: Results of a survival analysis of short-term follow-up data from a clinical database

Web-based self-management for patients with multiple sclerosis: a practical, randomized trial

Primary progressive multiple sclerosis as a phenotype of a PLP1 gene mutation

Sex differences in cytokine responses to myelin peptides in multiple sclerosis

Quantification of Self-Recognition in Multiple Sclerosis by Single-Cell Analysis of Cytokine Production

Eight-year immunogenicity and safety of interferon beta-1a-Avonex®treatment in patients with multiple sclerosis

Brain atrophy and magnetization transfer ratio following methylprednisolone in multiple sclerosis: short-term changes and long-term implications

Interferon gamma responses to myelin peptides in multiple sclerosis correlate with a new clinical measure of disease progression

Aktive Filter

Suchergebnisse filtern